Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumor Necrosis Factor-α
100%
In-hospital Mortality
100%
Tigecycline
100%
A-level
100%
Spontaneous Supratentorial Intracerebral Hemorrhage
100%
Number-needed-to-treat
66%
Clinical Outcomes
33%
Length of Stay
33%
Anti-inflammatory Activity
33%
Clinical Efficacy
33%
Postoperative Day
33%
Hematoma Evacuation
33%
Glasgow Outcome Scale
33%
Patient Outcomes
16%
Chi-square Test
16%
Surgical Procedures
16%
Inflammatory Response
16%
Prophylactic Antibiotics
16%
Mann-Whitney
16%
Hospital Discharge
16%
Brain Injury
16%
Before Surgery
16%
Neuroprotective Effect
16%
Brain CT
16%
Neuroprotective Activity
16%
Brain Edema
16%
In-hospital Mortality Rate
16%
Nursing and Health Professions
Brain Hemorrhage
100%
Tumor Necrosis Factor
100%
Tigecycline
100%
Numbers Needed to Treat
66%
Clinical Outcome
33%
Length of Stay
33%
Clinical Effectiveness
33%
Neuroprotective Agent
33%
Hematoma
33%
Antiinflammatory
33%
Glasgow Outcome Scale
33%
Inflammation
16%
Mortality Rate
16%
Chi Square Test
16%
Hospital Discharge
16%
X-Ray Computed Tomography
16%
Surgical Technique
16%
Brain Injury
16%
Brain Edema
16%
Antimicrobial Agent
16%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
100%
Brain Hemorrhage
100%
Tigecycline
100%
Number Needed to Treat
66%
Anti-Inflammatory Drug
33%
Neuroprotective Agent
33%
Hematoma
33%
Glasgow Outcome Scale
33%
Mortality Rate
16%
Inflammation
16%
Brain Injury
16%
Brain Edema
16%
Antimicrobial Agent
16%
Neuroscience
Cerebral Hemorrhage
100%
Tumor Necrosis Factor Alpha
100%
Tigecycline
100%
Hematoma
33%
Anti-Inflammatory
33%
Neuroprotective Agent
33%
Brain Injury
16%
Antimicrobial Agent
16%
X-Ray Computed Tomography
16%